Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Lee430on Apr 03, 2024 10:20am
98 Views
Post# 35967513

RE:RE:RE:RE:RE:Selling Sort1 Platform

RE:RE:RE:RE:RE:Selling Sort1 PlatformAssuming Zwick was recruited to smear some (maybe lots) of lipstick on our pig, then what is our little swine worth when the gavel is dropped at a livestock auction?

There have been several examples on this board of somewhat comparable buyouts mentioned that went for billions, so what would our little piggy fetch at market as of today or after maybe just meh TH1902 results, or drumroll please….good/great results?

I do not have the skillset to put a number down but here is my total WAG, at least $4B if PH1 results were just enough to squeal past the FDA for a TH1902 PH2 trial.

Mannequin wrote:

Theratechnologies is either a research company, which is an extension of the university or it’s what we have been told which is a company that has hired their own Salesforce to pick up new products and to push forward on the development of existing products and to execute on partnering opportunities with TH1902 and the sort1 platform. 

 

Never once have I been told that it is an extension of the university and their desire to fund jobs in Montreal. If that was the case, what did we need a $2 million a year CEO for?

 

There are all kinds of ways to bring in a partner to move forward into a phase 2 of 1902 if it looks like it has legs. There are also also numerous other way to execute and partner on clinical data. Surely we aren’t just here for the beer. Surely we must have invested all this time and money on the execution of what a company should do. And that is to exploit to the highest degree what assets we have. Surely a $2 million CEO doesn’t think that throwing it away for a few tens of millions of dollars and a future kicker is worth doing when the opportunity is in the billions. we can easily spool up an R&D centre and again easily. We know that. The skill set and education and labs and universities are there. But to just simply think that it’s appropriate to blow it all with a fat check and never participate and being in control of a platform we bought and paid and spent time waiting for simply to satisfy a short term mindset. I’m not here for the beer, I’m here for the whole thing or as much as we can get by leading it. 


palinc2000 wrote: I should add that a substantial upfront payment is very unlikely  and would be considered a windfall based on what is in the public domain.......Moreover finding a  partner with deep pocket is still a big challenge again based on what we know

I said many times before that going solo is NOT an option....Partnering is a must

palinc2000 wrote:

THTX does not have the financial means nor the expertise to carry this program ...
If they are able to find a buyer and get an upfront payment and milestone payments and a double digit royalty that would be FANTASTIC
Surprising that you cant see that
 


Mannequin wrote: I invested in the program and company not to just save their jobs so that they can sell it. That would be the only way they would ever do it. So that Paul can make his $2 million per year while somebody else gets rich if it works. If it doesn't work, they can dial it down, cut costs and still make money. Selling it would be ridiculous. 

 




 



<< Previous
Bullboard Posts
Next >>